Michael Wood | LifeSci Advisors |
Dror Harats | CEO & Director |
Amos Ron | CFO & Company Secretary |
Kevin DeGeeter | Oppenheimer |
Jonathan Aschoff | ROTH Capital Partners |
Swayampakula Ramakanth | H.C. Wainwright & Co. |
Jonathan Kreizman | Valore Research |
Greetings and welcome to the VBL Therapeutics Second Quarter 2020 Earnings Conference Call. [Operator Instructions].
As a reminder, this conference is being recorded. It is now my pleasure to introduce your host, Michael Wood of LifeSci Advisors. Please go ahead, sir.